Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2026-01-19 @ 4:41 AM
Study NCT ID:
NCT01134666
Status:
TERMINATED
Last Update Posted:
2017-06-09
First Post:
2010-05-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observational Study to Evaluate the Safety and Efficacy of FOLFIRI / FOLFOX Plus Cetuximab as First-line Therapy in Patients With KRAS Wild-type Metastatic Colorectal Cancer
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2013-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08-05
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-28
First Submit QC Date:
None
Study First Post Date:
2010-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-08
Last Update Post Date:
2017-06-09
Last Update Post Date Type:
ACTUAL